Table of Content

Strategic Imperatives
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Logistics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Opportunity Analysis
Scope of Analysis
Segmentation
Market Dynamics
Market Dynamics (continued)
Value Chain Analysis
Key Competitors
Vendor Landscape
Growth Drivers for Pharmaceutical Logistics
Growth Restraints for Pharmaceutical Logistics
Regional Analysis—North America (NA)
Regional Analysis—Europe
Regional Analysis—United Kingdom (UK)
Regional Analysis—Asia-Pacific (APAC)
Contract-logistics-provider-related Developments
Contract-logistics-provider-related Developments (continued)
Supply-chain-solution-provider-related Developments
Supply-chain-solution-provider-related Developments (continued)
CDMO-r
CDMO-r (continued)
CRO-related Developments
CRO-related Developments (continued)
Pharma LogisticsPrimed for Business Model Disruption
Growth Opportunity Universe
Growth Opportunity Universe—A Summary
Growth Opportunity Universe Summary
Growth Opportunity 1: Repurposing Cold Chain Capabilities
Growth Opportunity 1: Repurposing Cold Chain Capabilities (continued)
Global Cold-Chain Products Sales
Global Cold-Chain Products Sales (continued)
Global Cold-Chain Logistics Spending
Global Cold-Chain Logistics Spending
Growth Opportunity 2: Hybrid Trial Logistics
Growth Opportunity 2: Hybrid Trial Logistics (continued)
Case Study—DHL
Case Study—Marken (UPS)
Growth Opportunity 3: Improved Last-mile Connectivity
Growth Opportunity 3: Improved Last-mile Connectivity (continued)
eCommerce—Disrupting the Traditional Supply Chain Model
Case Study—Capsule
Growth Opportunity 4: Predictive Supply Chain
Growth Opportunity 4: Predictive Supply Chain (continued)
Case Study—Trek Therapeutics Uses Ambrosus’ Blockchain Solution for Quality Control
Case Study—Macro-Eyes’ ML Solutions Bring Predictability to the Vaccine Supply Chain
Companies to Action
List of Exhibits
Legal Disclaimer